Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Diabetes Care. 2020 Feb;43(2):e30-e31. doi: 10.2337/dci19-0067.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 2*
  • Gallbladder
  • Humans
  • Hypoglycemic Agents
  • Liraglutide

Substances

  • Hypoglycemic Agents
  • Liraglutide

Associated data

  • ClinicalTrials.gov/NCT01179048